US IDE trial finds embolization “safe and efficacious” for benign prostatic hyperplasia
A prospective US FDA-approved investigational device exemption (IDE) study has demonstrated significant improvement in lower urinary tract symptoms secondary to benign prostatic hyperplasia and...
Percutaneous ablation outperforms surgery in the treatment of renal cell carcinoma
Percutaneous ablation can be successfully used to treat many cases of early-stage renal cell carcinoma, a new study published in the Annals of Internal...
First-ever CE mark of a bioresorbable scaffold for below-the-knee PAD
Reva Medical, a company developing bioresorbable polymer technologies for vascular applications, has announced that its Motiv bioresorbable scaffold is the first drug-eluting bioresorbable scaffold...
New augmented reality system lets IRs “literally see through the patient”
European Radiology Experimental has recently published a study on a new augmented reality system that is able to accurately guide interventional oncology procedures. A three-step...
(Visited 6,881 times, 1 visits today)
